Teva Pharmaceutical Industries Ltd Stock Performance
as on October 23, 2025 at 10:40 pm IST
Day's Low
Day's High
$18.84$19.18
0.89%
Downside
0.89%
Upside
52 Week's Low
52 Week's High
$12.47$22.834.43%
Downside
19.94%
Upside
Teva Pharmaceutical Industries Ltd share price movements today
- Previous Close
- $18.97
- Open
- $19.08
- Volume
- 3.2M
- Day's Low - High
- $18.84 - $19.18
- 52 Week Low - High
- $12.47 - $22.8
Teva Pharmaceutical Industries Ltd Historical Returns
- 1 Month Return
- -2.47 %
- 3 Month Return
- + 14.41 %
- 1 Year Return
- + 3.04 %
- 3 Year Return
- + 124.76 %
- 5 Year Return
- + 102.89 %
Teva Pharmaceutical Industries Ltd Stock Fundamentals & Key Indicators
Check Teva Pharmaceutical Industries Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$21.2B
EPS (TTM)
2.5751
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
30.17
Industry PE ratio
19.200384615384614
PEG Ratio
1.2934
EBITDA
-
Revenue (TTM)
-
Profit Margin
-0.94%
Return On Equity TTM
-2.42%
Teva Pharmaceutical Industries Ltd Stock Valuation
Track how Teva Pharmaceutical Industries Ltd P/E has moved over time to understand its valuation trends.
Teva Pharmaceutical Industries Ltd in the last 5 years
Lowest (3.34x)
March 31, 2022
Industry (19.20x)
October 23, 2025
Today (30.17x)
October 23, 2025
Highest (12.90x)
December 31, 2024
Today’s Price to Earnings Ratio: 30.17x
Teva Pharmaceutical Industries Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Teva Pharmaceutical Industries Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| $21.2B | 102.89% | 30.17 | -0.94% | ||
| BUY | $19.6B | NA | 16.44 | 40.36% | |
| BUY | $42.0B | NA | 20.73 | 13.81% | |
| BUY | $14.0B | 42.88% | 41.85 | 13.88% | |
| BUY | $65.2B | -10.02% | 25.32 | 27.83% |
Stock Returns calculator for Teva Pharmaceutical Industries Ltd Stock including INR - Dollar returns
The Teva Pharmaceutical Industries Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Teva Pharmaceutical Industries Ltd investment value today
Current value as on today
₹1,07,912
Returns
₹7,912
(+7.91%)
Returns from Teva Pharmaceutical Industries Ltd Stock
₹3,259 (+3.26%)
Dollar Returns*
₹4,653 (+4.65%)
Analyst Recommendation on Teva Pharmaceutical Industries Ltd Stock
Based on 9 analysts
0.00%
Buy
33.33%
Hold
66.67%
Sell
Based on 9 analysts, 66.67% of analysts recommend a 'SELL' rating for Teva Pharmaceutical Industries Ltd. Average target price of $23.56
Teva Pharmaceutical Industries Ltd Share Price Target
Get share price movements and forecasts by analysts on Teva Pharmaceutical Industries Ltd.
What analysts predicted
19.31%UPSIDE
Target Price
$23.56
Current Price
$19.01
Analyzed by
9 Analysts
Target
$23.56
Teva Pharmaceutical Industries Ltd target price $23.56, a slight upside of 19.31% compared to current price of $19.01. According to 9 analysts rating.
Teva Pharmaceutical Industries Ltd Stock’s Investor Sentiment and Interest
Search interest for Teva Pharmaceutical Industries Ltd Stock has increased by 88% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:88% versus previous 30 day period
Teva Pharmaceutical Industries Ltd Quarterly Profit & Loss
All numbers in Millions USD
Teva Pharmaceutical Industries Ltd Annual Profit & Loss
All numbers in Millions USD
Teva Pharmaceutical Industries Ltd News & Key Events
Today's Timeline - 21 October
Tue, 03:22 PM
-Bank of America raises Teva's price target from $22 to $24, maintaining a Buy rating.
Tue, 07:25 PM
-Teva's stock shows potential for 28.12% upside, with analysts raising earnings estimates.
Tue, 09:30 PM
-Teva upgraded to Zacks Rank #2 (Buy) due to rising earnings estimates.
Insights on Teva Pharmaceutical Industries Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, TEVA has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 5 quarters, -845.0M → 282.0M (in $), with an average increase of 105.1% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 3.89B → 4.17B (in $), with an average increase of 6.8% per quarter
- POSITIVE IMPACT
Price Rise
In the last 3 years, TEVA stock has moved up by 124.8%
NO EFFECTAgainst Peers
In the last 1 year, Neurocrine Biosciences Inc. has given 22.9% return, outperforming this stock by 19.9%
About Teva Pharmaceutical Industries Ltd
| Organisation | Teva Pharmaceutical Industries Ltd |
| Headquarters | 124 Dvora HaNevi?a St., Tel Aviv, Israel, 6944020 |
| Industry | Health Technology |
| CEO | Mr. Richard D. Francis |
| E-voting on shares | Click here to vote |
Key Management of Teva Pharmaceutical Industries Ltd
Name | Title |
|---|---|
Mr. Amir Weiss | Senior VP & Chief Accounting Officer |
Mr. Richard Gordon Daniell | Executive Vice President of European Commercial |
Mr. Matthew Shields | Executive Vice President of Global Operations |
Ms. Christine Fox | Executive VP of U.S. Commercial Business |
Mr. David R. Mcavoy J.D. | Executive VP & Chief Legal Officer |
Mr. Eliyahu Sharon Kalif | Executive VP & CFO |
Mr. Richard D. Francis | President, CEO & Director |
Mr. Christopher J. Stevo CFA | Senior Vice President of Investor Relations & Competitive Intelligence |
Dr. Eric A. Hughes M.D., Ph.D. | Executive VP of Global R&D and Chief Medical Officer |
Kathleen Veit | Senior Vice President, Global Compliance & Ethics Officer |
FAQs
What is Teva Pharmaceutical Industries Ltd share price today?
Teva Pharmaceutical Industries Ltd share price today is $19.01 as on . Teva Pharmaceutical Industries Ltd share today touched a day high of $19.18 and a low of $18.84.
What is the 52 week high and 52 week low for Teva Pharmaceutical Industries Ltd share?
Teva Pharmaceutical Industries Ltd share touched a 52 week high of $22.8 on and a 52 week low of $12.47 on . Teva Pharmaceutical Industries Ltd stock price today i.e. is trending at $19.01,which is 16.62% down from its 52 week high and 52.51% up from its 52 week low.
What is Teva Pharmaceutical Industries Ltd's market capitalisation today?
Teva Pharmaceutical Industries Ltd market capitalisation is $0.02T as on .
How to invest in Teva Pharmaceutical Industries Ltd Stock (TEVA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Teva Pharmaceutical Industries Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Teva Pharmaceutical Industries Ltd Shares that will get you 0.0789 shares as per Teva Pharmaceutical Industries Ltd share price of $19.01 per share as on October 23, 2025 at 10:40 pm IST.
What is the minimum amount required to buy Teva Pharmaceutical Industries Ltd Stock (TEVA) from India?
Indian investors can start investing in Teva Pharmaceutical Industries Ltd (TEVA) shares with as little as ₹87.835 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.35 in Teva Pharmaceutical Industries Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Teva Pharmaceutical Industries Ltd share’s latest price of $19.01 as on October 23, 2025 at 10:40 pm IST, you will get 0.5260 shares of Teva Pharmaceutical Industries Ltd. Learn more about
fractional shares .
What are the returns that Teva Pharmaceutical Industries Ltd has given to Indian investors in the last 5 years?
Teva Pharmaceutical Industries Ltd stock has given 102.89% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?